|
private:stemcelltheranostics
|
3790474
|
Dec 3rd, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Dec 3rd, 2020 01:19PM
|
Dec 3rd, 2020 01:19PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Dec 2nd, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Dec 2nd, 2020 04:31PM
|
Dec 2nd, 2020 04:31PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Dec 1st, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Dec 1st, 2020 02:59PM
|
Dec 1st, 2020 02:59PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Nov 30th, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Nov 29th, 2020 09:00PM
|
Nov 30th, 2020 03:50PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Nov 28th, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Nov 28th, 2020 04:36PM
|
Nov 28th, 2020 04:36PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Nov 27th, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Nov 27th, 2020 01:02PM
|
Nov 27th, 2020 01:02PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Nov 26th, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Nov 25th, 2020 07:55PM
|
Nov 25th, 2020 07:55PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Nov 24th, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Nov 24th, 2020 03:28PM
|
Nov 24th, 2020 03:28PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Nov 23rd, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
5.00
|
Open
|
Biotechnology
|
Nov 23rd, 2020 05:17PM
|
Nov 23rd, 2020 05:17PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|
|
private:stemcelltheranostics
|
3790474
|
Nov 22nd, 2020 12:00AM
|
Stem Cell Theranostics
|
1.5K
|
4.00
|
Open
|
Biotechnology
|
Nov 22nd, 2020 04:14PM
|
Nov 22nd, 2020 04:14PM
|
Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
|
|
CardioModels - disease models custom designed for your needs, CardioScreens - tailored efficacy and toxicity screening programs, Discovery Partnerships - integrated partnership program to discover new targets, pathways, mechanisms and drug candidates
|
Open
|
640 Galveston Drive
|
Redwood City
|
California
|
US
|
94063
|
|
Stem Cell Theranostics
|
|
Pharmaceuticals & Biotechnology
|